Timeline

Anastasia V. Komarova

Permanent Researcher

26 Mar 2025

publication

Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization.

07 Oct 2024

publication

Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection.

09 Mar 2024

publication

Comparative analysis of rabies pathogenic and vaccine strains detection by RIG-I-like receptors.

05 Feb 2024

team

Institut Pasteur-Oncovita joint laboratory

01 Jan 2024

publication

Applying Reverse Genetics to Study Measles Virus Interactions with the Host.

30 Sep 2023

publication

Novel Antiviral Molecules against Ebola Virus Infection.

11 Mar 2023

publication

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.

01 Feb 2023

publication

Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.

18 Jan 2023

team

Interactomics, RNA and immunity

15 Jul 2022

publication

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.

01 Mar 2022

publication

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.

14 Dec 2021

project

Towards understanding of immunostimulatory properties of SARS-CoV-2 RNAs

01 Dec 2021

publication

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.

22 Oct 2021

publication

A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques.

09 Jun 2021

publication

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

27 Jan 2021

publication

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex.

13 Jan 2020

publication

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.

11 Dec 2019

publication

An RNA-Binding Protein Secreted by a Bacterial Pathogen Modulates RIG-I Signaling.

01 Oct 2019

publication

LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.

01 Apr 2019

publication

Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.

01 Apr 2019

publication

Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya.

01 Jan 2019

publication

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

01 Oct 2018

publication

DI-tector: defective interfering viral genomes’ detector for next-generation sequencing data.

10 Jul 2018

publication

RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes.

10 Jul 2018

publication

RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes.

15 Oct 2017

publication

Nonencapsidated 5′ Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.

24 Mar 2016

publication

Comparative analysis of viral RNA signatures on different RIG-I-like receptors.

14 Sep 2015

project

HIV signature on RIG-I-like receptors

02 Mar 2015

publication

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.

05 May 2014

publication

High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses

04 Jun 2013

publication

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

01 Apr 2013

publication

Identification of RNA partners of viral proteins in infected cells.

12 Sep 2011

publication

Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

18 Sep 2009

publication

Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor

01 Jan 2009

publication

Virus versus host cell translation love and hate stories

19 Nov 2008

publication

mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1

07 Feb 2007

publication

Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis

13 Oct 2006

publication

Evidence that PTB does not stimulate HCV IRES-driven translation

15 Aug 2006

publication

Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3

01 Jan 2006

publication

The case for mRNA 5′ and 3′ end cross talk during translation in a eukaryotic cell

01 Sep 2005

publication

[An Escherichia coli strain producing a leaderless mRNA from the chromosomal lac promoter]

01 Feb 2005

publication

AU-rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli

01 Dec 2003

publication

A key role for the mRNA leader structure in translational control of ribosomal protein S1 synthesis in gamma-proteobacteria

01 Sep 2002

publication

Protein S1 counteracts the inhibitory effect of the extended Shine-Dalgarno sequence on translation

01 Jul 2001

publication

A little guide for advanced search:

Multimodal SARS-CoV-2 interactome sketches the virus-host spatial organization.

Profiling Cullin4-E3 ligases interactomes and their rewiring in influenza A virus infection.

Comparative analysis of rabies pathogenic and vaccine strains detection by RIG-I-like receptors.

Institut Pasteur-Oncovita joint laboratory

Applying Reverse Genetics to Study Measles Virus Interactions with the Host.

Novel Antiviral Molecules against Ebola Virus Infection.

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys.

Antagonism of ALAS1 by the Measles Virus V protein contributes to degradation of the mitochondrial network and promotes interferon response.

Interactomics, RNA and immunity

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.

Towards understanding of immunostimulatory properties of SARS-CoV-2 RNAs

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters.

A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques.

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65-iASPP Protein Complex.

Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus.

An RNA-Binding Protein Secreted by a Bacterial Pathogen Modulates RIG-I Signaling.

LGP2 binds to PACT to regulate RIG-I- and MDA5-mediated antiviral responses.

Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.

Measles-vectored vaccine approaches against viral infections: a focus on Chikungunya.

Recombinant measles vaccine expressing malaria antigens induces long-term memory and protection in mice.

DI-tector: defective interfering viral genomes’ detector for next-generation sequencing data.

RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes.

RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes.

Nonencapsidated 5′ Copy-Back Defective Interfering Genomes Produced by Recombinant Measles Viruses Are Recognized by RIG-I and LGP2 but Not MDA5.

Comparative analysis of viral RNA signatures on different RIG-I-like receptors.

HIV signature on RIG-I-like receptors

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.

High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

Identification of RNA partners of viral proteins in infected cells.

Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor

Virus versus host cell translation love and hate stories

mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1

Rabies virus matrix protein interplay with eIF3, new insights into rabies virus pathogenesis

Evidence that PTB does not stimulate HCV IRES-driven translation

Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3

The case for mRNA 5′ and 3′ end cross talk during translation in a eukaryotic cell

[An Escherichia coli strain producing a leaderless mRNA from the chromosomal lac promoter]

AU-rich sequences within 5′ untranslated leaders enhance translation and stabilize mRNA in Escherichia coli

A key role for the mRNA leader structure in translational control of ribosomal protein S1 synthesis in gamma-proteobacteria

Protein S1 counteracts the inhibitory effect of the extended Shine-Dalgarno sequence on translation

[Extensive complementarity of the Shine-Dalgarno region and 3′-terminal sequence of 16S ribosomal RNA is inefficient for translation in vivo]